Stem cell-derived beta cells (SC-β-cells) engrafted into mice serve as a pre-clinical model of diabetes. It is helpful to recover viable β cells following transplantation to perform tests on the graft. We developed a protocol to retrieve and purify a sufficient number of live β cells from mice following long-term human SC-β-cell engraftment. The protocol enables examination of SC-β-cells undergoing developmental and metabolic changes and may facilitate the understanding of metabolic demand on SC-β-cells.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319362 | PMC |
http://dx.doi.org/10.1016/j.xpro.2021.100675 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!